49,424 Shares in Cigna Group $CI Purchased by Baker Ellis Asset Management LLC

Baker Ellis Asset Management LLC bought a new position in shares of Cigna Group (NYSE:CI) during the 3rd quarter, HoldingsChannel reports. The fund bought 49,424 shares of the health services provider’s stock, valued at approximately $13,435,000. Cigna Group accounts for approximately 1.4% of Baker Ellis Asset Management LLC’s holdings, making the stock its 20th largest holding.

Several other hedge funds and other institutional investors also recently made changes to their positions in CI. Osbon Capital Management LLC bought a new position in Cigna Group in the second quarter valued at about $26,000. Johnson Financial Group Inc. acquired a new position in Cigna Group in the 2nd quarter worth about $29,000. Fiduciary Financial Advisors bought a new position in Cigna Group in the second quarter valued at about $29,000. Cedar Mountain Advisors LLC grew its holdings in shares of Cigna Group by 161.9% during the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock worth $29,000 after purchasing an additional 68 shares during the last quarter. Finally, ANTIPODES PARTNERS Ltd bought a new stake in Cigna Group during the 2nd quarter worth approximately $34,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Cigna Group Stock Performance

Shares of CI stock traded up $7.04 during trading on Wednesday, hitting $289.57. The company’s stock had a trading volume of 1,396,313 shares, compared to its average volume of 1,671,362. The business has a fifty day moving average of $277.60 and a 200-day moving average of $281.29. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. Cigna Group has a 52 week low of $239.51 and a 52 week high of $311.34. The company has a market cap of $76.52 billion, a PE ratio of 11.98, a P/E/G ratio of 0.96 and a beta of 0.29.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company had revenue of $71.56 billion during the quarter, compared to analyst estimates of $70.14 billion. During the same quarter last year, the business posted $7.20 EPS. Cigna Group’s quarterly revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, research analysts anticipate that Cigna Group will post 30.50 earnings per share for the current year.

Cigna Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th were given a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date was Tuesday, September 8th. Cigna Group’s dividend payout ratio (DPR) is 25.82%.

Analyst Ratings Changes

CI has been the topic of a number of analyst reports. UBS Group reiterated a “buy” rating on shares of Cigna Group in a research report on Thursday, October 1st. Wells Fargo & Company boosted their target price on shares of Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. Robert W. Baird set a $362.00 price target on Cigna Group in a research note on Friday, July 31st. Piper Sandler set a $370.00 target price on shares of Cigna Group and gave the company an “overweight” rating in a research report on Friday, October 2nd. Finally, Raymond James Financial lowered shares of Cigna Group from a “strong-buy” rating to an “outperform” rating and dropped their price objective for the company from $350.00 to $320.00 in a report on Monday, August 3rd. Fifteen investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat, Cigna Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $338.24.

Insider Transactions at Cigna Group

In related news, insider Nicole Jones sold 19,436 shares of the firm’s stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the transaction, the insider directly owned 27,256 shares of the company’s stock, valued at approximately $7,530,015.12. This trade represents a 41.63% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the company’s stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the sale, the insider directly owned 5,053 shares of the company’s stock, valued at approximately $1,435,304.65. This represents a 10.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 22,730 shares of company stock valued at $6,293,359 over the last quarter. Company insiders own 0.60% of the company’s stock.

Cigna Group Company Profile

The Cigna Group (NYSE: CI) is a global health company that provides health care and related services to individuals, employers, government organizations and health plans. Its operations are primarily organized through Cigna Healthcare and Evernorth Health Services, which together address health coverage, pharmacy services, care delivery and benefit management.

Cigna Healthcare offers medical, dental, behavioral health, disability and other benefits, with a focus on employer-sponsored and individual health plans in the United States as well as international health services.